Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KRYS Krystal Biotech Inc.

交易中 11-22 11:59:02 EST

187.02

+4.73

+2.59%

最高188.22	最低182.02	成交量4.70万
今开184.07	昨收182.29	日振幅3.40%
总市值53.79亿	流通市值42.50亿	总股本2,876万
成交额873.89万	换手率0.21%	流通股本2,272万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KRYS","market":"US","secType":"STK","nameCN":"Krystal Biotech Inc.","latestPrice":187.02,"timestamp":1732294739489,"preClose":182.29,"halted":0,"volume":46995,"delay":0,"floatShares":22724632,"shares":28760548,"eps":1.77316,"marketStatus":"交易中","marketStatusCode":2,"change":4.73,"latestTime":"11-22 11:59:02 EST","open":184.07,"high":188.22,"low":182.02,"amount":8738862.1749,"amplitude":0.034012,"askPrice":187.11,"askSize":40,"bidPrice":186.72,"bidSize":50,"shortable":3,"etf":0,"ttmEps":1.77316,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1505880000000,"adjPreClose":182.29,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":185,"preClose":182.29,"latestTime":"09:23 EST","volume":729,"amount":133884.96885,"timestamp":1732285386669},"postHourTrading":{"tag":"盘后","latestPrice":182.29,"preClose":182.29,"latestTime":"16:20 EST","volume":2560,"amount":466656.93,"timestamp":1732224041347},"volumeRatio":0.514445,"impliedVol":0.4695,"impliedVolPercentile":0.3056},"requestUrl":"/m/hq/s/KRYS/wiki","defaultTab":"wiki","newsList":[{"id":"2482273811","title":"Krystal Biotech, Inc.涨1.32% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2482273811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482273811?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335558,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分，Krystal Biotech, Inc.股票出现异动，股价快速上涨1.32%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为410.56%、133.35%、65.85%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aptevo Therapeutics Inc.、Eupraxia Pharmaceuticals Inc.，振幅分别为32.57%、10.27%、10.20%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122323895be107b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122323895be107b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2482422105","title":"Krystal Biotech, Inc.2024财年第三财季实现净利润27.18百万美元，同比减少66.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422105?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:02","pubTimestamp":1731168145,"startTime":"0","endTime":"0","summary":"11月10日，Krystal Biotech, Inc.公布财报，公告显示公司2024财年第三财季净利润为27.18百万美元，同比减少66.34%；其中营业收入为83.84百万美元，同比增加879.44%，每股基本收益为0.95美元。机构评级：截至2024年11月10日，当前有9家机构对Krystal Biotech, Inc.目标价做出预测，其中目标均价为207.56美元，其中最低目标价为195.00美元，最高目标价为221.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000259abb100ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000259abb100ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS"],"gpt_icon":0},{"id":"2481855539","title":"Krystal Biotech, Inc.盘中异动 急速上涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481855539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481855539?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:37","pubTimestamp":1730903861,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时37分，Krystal Biotech, Inc.股票出现波动，股价快速上涨5.46%。截至发稿，该股报183.94美元/股，成交量1.8835万股，换手率0.07%，振幅2.69%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、122.99%、57.31%，振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Uniqure N.V.，振幅分别为107.44%、106.04%、105.12%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622374195bddd1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622374195bddd1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"1186706190","title":"异动解读 | 医药生物科技股克赖斯博士股份股价大跌 高市盈率或资金流出可能是压力来源","url":"https://stock-news.laohu8.com/highlight/detail?id=1186706190","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186706190?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:16","pubTimestamp":1730769382,"startTime":"0","endTime":"0","summary":"在公布了2024年第三季度超预期业绩后,医药生物科技公司克赖斯博士股份4日盘中股价仍出现6.74%的大跌,报165美元,引发市场关注。但即便出现了不俗的业绩表现,克赖斯的股价在4日早盘遭遇大幅下跌。一方面是克赖斯目前的高市盈率达到41.77倍,估值较高可能使其股价面临较大下行压力。另一方面,克赖斯近期也出现了一定程度的资金净流出,数据显示大约有3000万美元资金离场,其中大资金净流出金额高达1000万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KRYS"],"gpt_icon":0},{"id":"1142391321","title":"异动解读 | Krystal Biotech Inc.遭遇大跌 超预期业绩未能扭转颓势","url":"https://stock-news.laohu8.com/highlight/detail?id=1142391321","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142391321?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:24","pubTimestamp":1730733862,"startTime":"0","endTime":"0","summary":"北京时间2024年11月4日,医疗生物技术公司Krystal Biotech Inc.盘中大跌6.74%,股价报165美元,引发市场广泛关注。公司此前公布了2024年第三季度超预期的业绩,但似乎并未影响股价的下跌趋势。根据财报数据,Krystal Biotech第三季度实现营收8384万美元,同比增长879.9%,超过分析师预期的8295万美元。Krystal Biotech目前市盈率高达41.77倍,使其股价面临较大压力。此外,数据显示该股近期资金净流出3000万美元,大资金净流出达1000万美元,也可能导致股价承压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["KRYS"],"gpt_icon":0},{"id":"2480587355","title":"Krystal 生物技术公司公布截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587355","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480587355?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:20","pubTimestamp":1730733618,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc   公布的截至1月1日的季度调整后每股收益为91美分，高于去年同期的每股收益-69美分。华尔街预期为每股收益 63 美分至 1.16 美元。* Krystal Biotech Inc公布的本季度每股收益为91美分。* 公司报告的季度净收入为 2718 万美元。* Krystal Biotech Inc本季度股价下跌了3.1%，今年迄今为止上涨了42.2%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 206.00 美元。本摘要由 LSEG 11 月 4 日 03:19 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Krystal 生物技术公司公布截至 1 月 1 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2480581656","title":"Krystal Biotech, Inc.盘中异动 早盘股价大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581656","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581656?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:32","pubTimestamp":1730730746,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时32分，Krystal Biotech, Inc.股票出现波动，股价大幅跳水6.46%。截至发稿，该股报165.00美元/股，成交量1.6146万股，换手率0.06%，振幅1.72%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为234.93%、128.40%、42.86%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.，振幅分别为29.83%、22.67%、12.78%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322695bdc9ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422322695bdc9ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2458692795","title":"Krystal Biotech, Inc.2024财年第二财季实现净利润15.57百万美元，同比增加146.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458692795","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458692795?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:09","pubTimestamp":1723392588,"startTime":"0","endTime":"0","summary":"8月12日，Krystal Biotech, Inc.公布财报，公告显示公司2024财年第二财季净利润为15.57百万美元，同比增加146.88%；其中营业收入为70.28百万美元，每股基本收益为0.54美元。从资产负债表来看，Krystal Biotech, Inc.总负债78.77百万美元，其中短期债务1.36百万美元，资产负债比为0.12，流动比率为0.10。机构评级：截至2024年8月12日，当前有9家机构对Krystal Biotech, Inc.目标价做出预测，其中目标均价为202.00美元，其中最低目标价为193.00美元，最高目标价为208.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812000958959041da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812000958959041da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS"],"gpt_icon":0},{"id":"1128122949","title":"异动解读 | Krystal Biotech Inc.盘前大跌13.24%,财报数据或成主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1128122949","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128122949?lang=zh_cn&edition=full","pubTime":"2024-08-05 22:14","pubTimestamp":1722867274,"startTime":"0","endTime":"0","summary":"Krystal Biotech Inc.今日盘前大跌13.24%,引发市场广泛关注。分析人士认为,该公司最新一季度财报数据可能是导致股价大跌的主要原因。Krystal Biotech Inc.公布的截至6月底的季度调整后每股收益为0.53美元,虽然高于去年同期的每股收益1.25美元,但低于华尔街分析师平均预期的0.58美元。另外,过去三个月内,分析师对该公司的盈利预期下降约6.7%,这可能也是导致股价下跌的一个原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS"],"gpt_icon":0},{"id":"2457720901","title":"Krystal 生物技术公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457720901","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457720901?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:31","pubTimestamp":1722864676,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc   公布的截至6月底的季度调整后每股收益为53美分，高于去年同期的每股收益1.25美元。华尔街预期为每股收益 37 美分至 96 美分。* Krystal Biotech Inc公布的季度每股收益为53美分。* 公司报告的季度净收入为 1557 万美元。* Krystal Biotech Inc 本季度股价上涨了 4.5%，今年迄今为止上涨了 54.7%。8月5日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 6.7%。* 生物技术与医学研究同行的平均一致建议为 \"买入\"。华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 195.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Krystal 生物技术公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2457729201","title":"Krystal Biotech(KRYS.US)：2024年Q2财报实现营收7028.4万美元，前值为0美元，预期值为6443万美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2457729201","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457729201?lang=zh_cn&edition=full","pubTime":"2024-08-05 20:04","pubTimestamp":1722859480,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2456736231","title":"Krystal Biotech Inc    预计每股收益 58 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456736231","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456736231?lang=zh_cn&edition=full","pubTime":"2024-08-03 00:01","pubTimestamp":1722614509,"startTime":"0","endTime":"0","summary":"   * Krystal Biotech Inc    将于8月5日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据8位分析师基于LSEG数据的平均预期，这家总部位于美国宾夕法尼亚州匹兹堡市的公司预计将实现6533.5万美元的营收。* LSEG 分析师对 Krystal Biotech Inc 的平均预期为每股收益 58 美分。* 华尔街对 Krystal Biotech Inc 的 12 个月目标价中位数为 195.00 美元，低于其最新收盘价 198.78 美元。8月2日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Krystal Biotech Inc    预计每股收益 58 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KRYS"],"gpt_icon":0},{"id":"2456843042","title":"Krystal Biotech, Inc.盘中异动 早盘急速跳水5.32%报188.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456843042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456843042?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605493,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，Krystal Biotech, Inc.股票出现波动，股价快速下跌5.32%。截至发稿，该股报188.21美元/股，成交量4503股，换手率0.02%，振幅0.50%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为214.51%、40.63%、16.51%，振幅较大的相关个股有Nuvation Bio Inc.、Xencor, Inc.、Molecular Partners Ag，振幅分别为9.01%、8.12%、8.00%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213134941fd89a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213134941fd89a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2455202930","title":"Krystal Biotech, Inc.跌0.71% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2455202930","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455202930?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:32","pubTimestamp":1722346330,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时32分，Krystal Biotech, Inc.股票出现异动，股价快速跳水0.71%。截至发稿，该股报203.74美元/股，成交量3631股，换手率0.01%，振幅2.72%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Imunon, Inc.、Processa Pharmaceuticals, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为745.17%、741.82%、579.35%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为46.22%、29.41%、10.57%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213210956d3d24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213210956d3d24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2452535974","title":"Krystal Biotech, Inc.跌3.53% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2452535974","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452535974?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:36","pubTimestamp":1721327788,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时36分，Krystal Biotech, Inc.股票出现波动，股价急速下挫3.53%。截至发稿，该股报199.98美元/股，成交量20.6988万股，换手率0.72%，振幅4.50%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体跌幅为1.21%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3224.27%、2593.41%、1301.02%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023628941f865a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023628941f865a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KRYS","BK4139"],"gpt_icon":0},{"id":"2450964913","title":"Krystal Biotech, Inc.涨3.40% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2450964913","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450964913?lang=zh_cn&edition=full","pubTime":"2024-07-12 01:17","pubTimestamp":1720718224,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日01时17分，Krystal Biotech, Inc.股票出现波动，股价急速拉升3.40%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。消息层面，截至01时17分，《斯迪富维持Krystal Biotech买入评级，维持目标价204美元》资讯为影响Krystal Biotech, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712011704941f6561&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712011704941f6561&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRYS"],"gpt_icon":0},{"id":"2442456941","title":"Krystal Biotech, Inc.盘中异动 临近午盘股价大涨5.07%报186.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442456941","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442456941?lang=zh_cn&edition=full","pubTime":"2024-06-12 23:32","pubTimestamp":1718206358,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日23时32分，Krystal Biotech, Inc.股票出现波动，股价大幅拉升5.07%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。消息层面，截至23时32分，《Form 144 | Krystal Biotech董事拟出售2.5万股股份，价值约442.08万美元》资讯为影响Krystal Biotech, Inc.的重要信息。该信息摘要如下：根据美国证券交易委员会美东时间6月11日披露的文件，$Krystal Biotech $董事SUMA KRISHNAN拟于6月11日出售2.5万股普通股股份，总市值约442.08万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612233239941ee1e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","KRYS","BK4139"],"gpt_icon":0},{"id":"2440917954","title":"Krystal Biotech, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440917954","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440917954?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:51","pubTimestamp":1717426277,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时51分，Krystal Biotech, Inc.股票出现波动，股价急速拉升5.26%。截至发稿，该股报168.47美元/股，成交量3.0799万股，换手率0.11%，振幅4.37%。Krystal Biotech, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Cingulate Inc C/Wts 10/12/2026 、Biocardia Inc C/Wts 06/08/2024涨幅较大，Bio-Path Holdings, Inc.、Scorpius Holdings, Inc.、Affimed N.V.较为活跃，换手率分别为2844.02%、101.21%、54.17%，振幅较大的相关个股有Affimed N.V.、Bio-Path Holdings, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为73.56%、72.82%、48.75%。Krystal Biotech, Inc.公司简介：Krystal Biotech Inc在美国从事医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225117941ebedf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603225117941ebedf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KRYS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.krystalbio.com","stockEarnings":[{"period":"1week","weight":0.0276},{"period":"1month","weight":0.0405},{"period":"3month","weight":-0.0957},{"period":"6month","weight":0.1195},{"period":"1year","weight":0.7868},{"period":"ytd","weight":0.4694}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Krystal Biotech, Inc.于2016年4月开始运营。2017年3月，他们从加利福尼亚州有限责任公司转换为特拉华州C-corporation，并将其名称从Krystal Biotech, LLC更改为Krystal Biotech, Inc。该公司是一家专注于为罕见病患者开发和商业化基因药物的生物技术公司。利用他们基于工程化HSV-1的专利平台，他们创造了载体，可以有效地将治疗性转基因传递给多器官系统中感兴趣的细胞。然后，细胞自身的机制转录并翻译编码的效应物来治疗或预防疾病。他们在医疗保健专业人员的办公室或可能由医疗保健专业人员在患者家中制定无创或微创给药途径的载体。他们的目标是开发易于使用的药物，以显著改善患有罕见疾病和慢性疾病的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.00628},{"month":2,"riseRate":0.714286,"avgChangeRate":0.089681},{"month":3,"riseRate":0.571429,"avgChangeRate":0.056874},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015567},{"month":5,"riseRate":0.571429,"avgChangeRate":0.051502},{"month":6,"riseRate":0.714286,"avgChangeRate":0.119067},{"month":7,"riseRate":0.714286,"avgChangeRate":0.070705},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.006823},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.071215},{"month":10,"riseRate":0.5,"avgChangeRate":0.044866},{"month":11,"riseRate":0.875,"avgChangeRate":0.189836},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.00422}],"exchange":"NASDAQ","name":"Krystal Biotech Inc.","nameEN":"Krystal Biotech Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Krystal Biotech Inc.,KRYS,Krystal Biotech Inc.股票,Krystal Biotech Inc.股票老虎,Krystal Biotech Inc.股票老虎国际,Krystal Biotech Inc.行情,Krystal Biotech Inc.股票行情,Krystal Biotech Inc.股价,Krystal Biotech Inc.股市,Krystal Biotech Inc.股票价格,Krystal Biotech Inc.股票交易,Krystal Biotech Inc.股票购买,Krystal Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Krystal Biotech Inc.(KRYS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Krystal Biotech Inc.(KRYS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况